## HRL: Hormel Foods Corporation - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_10 -1.0% below STRENGTH zone (3.0-6.0%); PEG 1.66 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($22.86)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 9
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Hormel names new chief marketing officer**
- Source: Supermarket Perimeter | 20251229T160324 | Bullish | Relevance: 100%
- Hormel Foods Corp. has appointed Jason Levine as its new enterprise-wide chief marketing officer, a newly created role. Levine brings over 20 years of experience in consumer-packaged goods, including leadership positions at Mondelēz International and PIM Brands. His focus will be on advancing marketing capabilities, brand strategy, and digital engagement to drive growth across Hormel's businesses.

**2. Hormel Foods Is Rebuilding the Center of the Plate for a Post-Pandemic Grocery Aisle**
- Source: AD HOC NEWS | 20251231T092156 | Bullish | Relevance: 100%
- Hormel Foods is undergoing a significant transformation, evolving from a legacy pantry brand known for SPAM and Skippy into a data-driven, diversified protein platform. The company is strategically repositioning its portfolio to offer convenient, affordable, and values-aligned protein options, addressing modern consumer demands and retail needs. This involves curating an ecosystem of brands, innovations, and ready-to-eat platforms to create a resilient engine for the protein market.

**3. Barclays Trims Hormel (HRL) Target as Agriculture Outlook Turns Uneven**
- Source: Insider Monkey | 20251230T200811 | Neutral | Relevance: 100%
- Barclays lowered its price target for Hormel Foods Corporation (NYSE: HRL) to $30 from $31, maintaining an Overweight rating, as the firm anticipates uneven results in agriculture markets for 2026. This adjustment is part of Barclays' broader outlook for the Americas agribusiness group, which favors seeds over crude protein. Separately, Hormel completed a transaction with Forward Consumer Partners for its JUSTIN’S brand, resulting in a joint ownership structure aimed at brand growth.

**4. Hormel Foods Is Rebuilding the Center of the Plate for a Post-Pandemic Grocery Aisle**
- Source: AD HOC NEWS | 20251231T090800 | Bullish | Relevance: 100%
- Hormel Foods is strategically reinventing its product portfolio, moving beyond traditional pantry staples to become a data-driven, diversified protein platform. This reinvention involves a curated ecosystem of brands, innovations, and ready-to-eat products designed to meet consumer demands for convenience, affordability, and modern values, while also strengthening its position against market rivals and securing long-term investor value. The company's approach focuses on brand architecture, protein-centric offerings, versatility across eating occasions, and incremental innovation to ensure continued relevance and growth in the competitive food market.

**5. Hormel Foods Foodservice Growth: Is This a Key Earnings Lever?**
- Source: TradingView — Track All Markets | 20251231T150754 | Somewhat-Bullish | Relevance: 95%
- Hormel Foods' Foodservice segment is a critical earnings driver, with net sales increasing 4% year-over-year in Q4 fiscal 2025, driven by value-added offerings despite volume declines. While profitability faced headwinds from commodity costs and a product recall, strong performance in high-value categories and broad channel exposure highlight its significance. The segment contributed roughly one-third of company revenues in fiscal 2025, with growth increasingly tied to product mix and branded solutions.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Barclays | $30 | $31 | -3% |
| 2025-12-05 | Piper Sandler | $26 | $25 | +4% |
| 2025-12-05 | JP Morgan | $28 | $27 | +4% |
| 2025-12-05 | B of A Securiti | $26 | $25 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Barclays | main | Overweight |
| 2025-12-05 | Piper Sandler | main | Neutral |
| 2025-12-05 | JP Morgan | main | Overweight |
| 2025-12-05 | B of A Securiti | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 8 ($0.00M) |
| Sells | 8 ($0.46M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 24.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 10 / 0 |

**Top Holders:**
- Vanguard Group Inc: 6.8% (+2.0%)
- State Street Corpora: 5.1% (+1.0%)
- Blackrock Inc.: 4.6% (+2.2%)
- Invesco Ltd.: 2.1% (+66.5%)
- Geode Capital Manage: 1.5% (+1.7%)

### Key Risks

1. Long-term trend broken: trading 12.8% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +4%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 1.66 elevated, pricing in significant growth expectations. Forward P/E 15.2x stretched relative to 6% growth. Balance sheet: strong liquidity (2.5x). Institutional flow bullish (10 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $13.0B |
| Beta | 0.33 |
| 52W Range | $21.03 - $32.07 |
| Short Interest | 6.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.66 |
| Forward P/E | 15.2 |
| Current P/E | 16.2 |
| YoY Growth | 6.3% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 0.1% to -1.0% (-1.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.0pp (needs >3.0% for momentum thesis). Below SMA200 (0.87x), long-term trend not supportive. RSI neutral at 50. OFD pattern: -MTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.02% (CS: 30) | Neutral |
| RSI_14 | 49.6 | Neutral |
| MACD Histogram | -0.04 | Bearish |
| vs SMA20 | 0.990x | Below |
| vs SMA50 | 1.024x | Above |
| vs SMA200 | 0.872x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $23.70
- **Stop Loss:** $22.86 (3.5% risk)
- **Target:** $24.54 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 1428
- **Position Value:** $33,843.60
- **Portfolio %:** 33.84%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with mixed signals requiring caution. VIX at 14.95 suggests calm markets, but record repo borrowing and narrowing breadth (51.4%) indicate stress beneath the surface. Positive yield curve (+62bps) and stable economic data support risk assets, but year-end dynamics mask true liquidity conditions.*

### Earnings

**Next:** 2026-02-26 (Est: $0.32)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.30 | $0.32 | +6.0% |
| 2025Q3 | $0.41 | $0.35 | -14.5% |
| 2025Q2 | $0.34 | $0.35 | +3.3% |
| 2025Q1 | $0.37 | $0.35 | -6.6% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*